Recombinant Cynomolgus Lymphotoxin beta R/TNFRSF3 Fc, CF
R&D Systems, part of Bio-Techne | Catalog # 10759-LR
Key Product Details
Source
CHO
Accession #
Structure / Form
Disulfide-linked homodimer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
Chinese Hamster Ovary cell line, CHO-derived cynomolgus monkey Lymphotoxin beta R/TNFRSF3 protein
Cynomolgus Monkey Lymphotoxin beta R/TNFRSF3 (Ser28-Met227) Accession # XP_005569951.1 |
IEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus |
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Ser28
Predicted Molecular Mass
48 kDa
SDS-PAGE
57-68 kDa, under reducing conditions
Activity
Measured by its ability to inhibit Lymphotoxin alpha1/ beta2-induced IL-8 secretion in A375 human melanoma cells. Degli-Esposti, M. et al. (1997) J. Immunol. 158:1756.
The ED50 for this effect is 30.0-180 ng/mL in the presence of 100 ng/mL Recombinant Human Lymphotoxin alpha1/ beta2 (Catalog # 8884-LY).
The ED50 for this effect is 30.0-180 ng/mL in the presence of 100 ng/mL Recombinant Human Lymphotoxin alpha1/ beta2 (Catalog # 8884-LY).
Scientific Data Images for Recombinant Cynomolgus Lymphotoxin beta R/TNFRSF3 Fc, CF
Recombinant Cynomolgus Monkey Lymphotoxin beta R/TNFRSF3 Fc Chimera Bioactivtiy.
Recombinant Cynomolgus Lymphotoxin beta R/TNFRSF3 Fc Chimera (Catalog # 10759-LR) inhibits Lymphotoxin alpha1/beta2-induced IL-8 secretion in A375 human melanoma cells. The ED50 for this effect is 30.0-180 ng/mL in the presence of 100 ng/mL Recombinant Human Lymphotoxin alpha1/beta2 (8884-LY).Recombinant Cynomolgus Monkey Lymphotoxin beta R/TNFRSF3 SDS-PAGE.
2 μg/lane of Recombinant Cynomolgus Monkey Lymphotoxin beta R/TNFRSF3 Fc Chimera (Catalog # 10759-LR) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 57-68 kDa and 114-136 kDa, respectively.Formulation, Preparation and Storage
10759-LR
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 500 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Lymphotoxin beta R/TNFRSF3
References
- Crowe, P.D. et al. (1994) Science 264:707.
- Force, W.R. et al. (1995) J. Immunol. 155:5280.
- McCarthy, D.D. (2006) Immunol. Res. 35:41.
- Tumanov, A.V. et al. (2007) Curr. Mol. Med. 7:567.
- Boehm, T. et al. (2003) J. Exp. Med. 198:757.
- Wolf, M.J. et al. (2010) Oncogene 29:5006.
- Bista, P. et al. (2010) J. Biol. Chem. 285:12971.
- van de Pavert, S.A. et al. (2010) Nat. Rev. Immunol. 10:664.
- Mouri, Y. et al. (2011) J. Immunol. 186:5047.
- Vondenhoff, M.F. et al. (2009) J. Immunol. 182:5439.
- Haybaeck, J. et al. (2009) Cancer Cell 16:295.
Long Name
Lymphotoxin beta Receptor
Alternate Names
LTBR, LymphotoxinbR, TNF RIII, TNF Rrp, TNFRSF3
Entrez Gene IDs
Gene Symbol
LTBR
UniProt
Additional Lymphotoxin beta R/TNFRSF3 Products
Product Documents for Recombinant Cynomolgus Lymphotoxin beta R/TNFRSF3 Fc, CF
Product Specific Notices for Recombinant Cynomolgus Lymphotoxin beta R/TNFRSF3 Fc, CF
For research use only
Loading...
Loading...
Loading...
Loading...